Clinical Trials on Hematological Disease
Total 381169 results
-
Cooperative Study Group A for HematologyCompletedHEMATOLOGIC MALIGNANCIESKorea, Republic of
-
Gamida Cell ltdCompletedTransplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HMHematological Malignancies | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States, Singapore, Spain, Netherlands, Italy
-
Medical University of ViennaCompleted
-
National Research Center for Hematology, RussiaNot yet recruitingHematologic Malignancy | Graft Versus Host Disease | Cyclophosphamide Adverse Reaction
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
A.O. Ospedale Papa Giovanni XXIIIRecruitingRelapsed Hematologic MalignancyItaly
-
Bristol-Myers SquibbExelixisTerminatedRefractory Hematologic CancerUnited States
-
University Health Network, TorontoCompletedCancer Rehabilitation | Hematologic Cancer | Allogeneic DiseaseCanada
-
Sinocelltech Ltd.RecruitingRelapsed or Refractory Hematologic MalignanciesChina
-
Mount Sinai Hospital, CanadaActive, not recruitingStem Cell Transplant | Hematologic MalignancyCanada
-
Surface OncologyCompletedHematologic Cancers | Advanced Solid CancersUnited States, Canada
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
Yonsei UniversityUnknownMalignant Hematologic DisorderKorea, Republic of
-
University of Milano BicoccaRecruitingMantle-cell Lymphoma | B Cell Chronic Lymphocytic LeukemiaItaly
-
University of California, San DiegoTerminated
-
Sichuan UniversityRecruitingHematologic MalignancyChina
-
Universitaire Ziekenhuizen KU LeuvenLeuvens Kanker InstituutCompletedHematologic Disease | Oncology, MedicalBelgium
-
Firas El Chaer, MDRecruitingHematologic Malignancy | Platelet RefractorinessUnited States
-
Northside Hospital, Inc.RecruitingTransplant-Related Hematologic MalignancyUnited States
-
Dialectic Therapeutics, IncCompletedSolid Tumor | Hematologic MalignancyUnited States
-
Institut de cancérologie Strasbourg EuropeCompletedHematologic Malignancy | Tumor, SolidFrance
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
King Faisal Specialist Hospital & Research CenterCompletedTransplantation for Hematologic MalignanciesSaudi Arabia
-
M.D. Anderson Cancer CenterBTG International Inc.Terminated
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Renal Insufficiency | Anemia | Thrombocytopenia | Coagulation Disorder | Stroke, Ischemic | Stroke Hemorrhagic | Bleeding Disorder | Hematological DiseaseChina, Spain, Belgium, Germany, Portugal, Switzerland, Hong Kong, United Kingdom, Austria, Italy, Netherlands, Singapore, Taiwan
-
Brno University HospitalRecruitingLymphoma | Hematologic MalignancyCzechia
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States, Australia
-
Chinese PLA General HospitalCompletedSolid Tumor | Hematologic MalignancyChina
-
Piramal Enterprises LimitedCompletedSolid Tumor | Hematologic MalignancyIndia
-
Constellation PharmaceuticalsNot yet recruitingSolid Tumor | Hematologic Malignancy | Advanced Malignancies
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingAdvanced Solid Tumors and Hematologic MalignanciesChina
-
Suzhou Junjing BioSciences Co., Ltd.RecruitingAdvanced Solid Tumors | Advanced Hematologic MalignanciesChina
-
Ascentage Pharma Group Inc.RecruitingAdvanced Solid Tumors or Hematologic MalignanciesUnited States
-
Massachusetts General HospitalMedically HomeActive, not recruiting
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.TerminatedHematologic MalignancyChina
-
Massachusetts General HospitalActive, not recruitingHematologic Malignancy | CAR-T Cell TherapyUnited States
-
Scripps Translational Science InstituteCompleted
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
University College, Londonbluebird bioActive, not recruitingPost-transplant Lymphoproliferative Disease | Transplant-Related Hematologic MalignancyUnited Kingdom
-
Princess Maxima Center for Pediatric OncologyRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyNetherlands
-
Memorial Sloan Kettering Cancer CenterTerminated
-
University of Michigan Rogel Cancer CenterCompletedHematologic Neoplasms | Graft vs Host Disease | Non-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Westlake TherapeuticsRecruitingCancer | Solid Tumor | Hematologic MalignancyChina
-
City of Hope Medical CenterNational Institute on Aging (NIA)Active, not recruitingCancer | Solid Tumor | Hematologic MalignancyUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Hackensack Meridian Health; Lombardi Comprehensive...CompletedStem Cell Transplantation | Hematologic MalignancyUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States